This inventor holds 1 USPTO granted patent. Top assignee: Yeditepe Üniversitesi. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Inci Kurt Celep and Biomarker Research for Endometriosis
Introduction
Inci Kurt Celep is an inventor associated with Yeditepe University in Istanbul, Türkiye. Her patent work focuses on identifying biological markers that may support the diagnosis of endometriosis.
Latest Patents
Celep is associated with 1 patent, titled “Biological Markers in the Diagnosis of Endometriosis.” The invention describes combinations of biological markers that are expressed differently in endometrial mesenchymal stem cells (eMSCs) from people with endometriosis compared with healthy eMSCs. It identifies tissue transglutaminase as a potential biomarker for diagnosing endometriosis using eMSCs obtained from endometrial biopsy samples and/or menstrual blood.
Career Highlights
The patent reflects research into potential diagnostic approaches based on biological differences in endometrial cells. By examining samples from endometrial biopsies or menstrual blood, the proposed method aims to identify markers that could help distinguish endometriosis from healthy conditions.
Collaborations
Celep’s listed coworkers include Melike Batukan and Dilek Telci Temeltas. Her work is associated with Yeditepe University.
Conclusion
Inci Kurt Celep’s patent centers on tissue transglutaminase and related biological markers as potential tools for endometriosis diagnosis, highlighting the role of biomarker research in developing diagnostic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile